000516.SZ SHZ
Xi'an International Medical Investment Company Limited
1W: +1.2%
1M: +6.3%
3M: +10.3%
YTD: -11.9%
1Y: -18.6%
3Y: -50.1%
5Y: -78.1%
¥4.37 ($0.65)
+0.10 (+2.34%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$1.0B
-7.2% ▼
Capital Expenditures
$548M
+28.2% ▲
5Y CAGR: -31.4%
Free Cash Flow
$461M
+42.1% ▲
Dividends Paid
$184M
+15.5% ▲
Buybacks
$57M
+0.0% ▲
Net Change in Cash
-$395M
-64.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $35M | -$845M | -$1.2B | -$368M | -$365M |
| Depreciation & Amort. | $376M | $569M | $620M | $784M | $731M |
| Stock-Based Comp. | $0 | $0 | $37M | $33M | $0 |
| Change in Working Capital | $222M | $325M | $720M | -$262M | $454M |
| Other Non-Cash Items | -$591M | $407M | $225M | $898M | $190M |
| Operating Cash Flow | $41M | $456M | $461M | $1.1B | $1.0B |
| — Investing Activities — | |||||
| Capital Expenditures | -$1.3B | -$1.7B | -$1.2B | -$763M | -$548M |
| Acquisitions (Net) | $51K | $475K | $160M | $0 | $0 |
| Investment Purchases | -$1.8B | -$3.5B | -$400M | -$3M | -$11M |
| Investment Sales | $2.1B | $4.0B | $513M | $24M | $52M |
| Other Investing | -$200K | $0 | $97M | -$21M | $496K |
| Investing Cash Flow | -$1.1B | -$1.2B | -$818M | -$762M | -$506M |
| — Financing Activities — | |||||
| Net Debt Issuance | $1.2B | $260M | $238M | -$264M | -$655M |
| Stock Repurchased | $0 | -$1.2B | -$4M | $0 | -$57M |
| Dividends Paid | -$196M | -$232M | -$245M | -$217M | -$184M |
| Other Financing | -$74M | $1.3B | $33M | -$84M | -$3M |
| Financing Cash Flow | $937M | $1.3B | $21M | -$565M | -$898M |
| Net Change in Cash | -$126M | $560M | -$336M | -$240M | -$395M |
| Cash End of Period | $959M | $1.5B | $1.2B | $944M | $549M |
| Free Cash Flow | -$1.3B | -$1.2B | -$727M | $325M | $461M |